论文信息 - PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab. - 字舞流文

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

A. Laenkholm | M. Andersson | E. Santoni-Rugiu | M. Ewertz | J. D. Jensen | M. Jensen | M. Grauslund | A. Knoop | A. Knoop | Ann S. Knoop